Popular search terms:
Search Results Label
15 results found-
Seqirus announces Health Canada approval of first cell-based seasonal influenza vaccine
Seqirus announces Health Canada approval of first cell-based seasonal influenza vaccine
https://www.seqirus.ca/news/seqirus-announces-health-canada-approval-of--first-cell-based-seasonal-influenza-vaccine -
Stephen Marlow
Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.
https://www.seqirus.ca/our-company/leadership/stephen-marlow -
Seqirus | About Us
Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world.
https://www.seqirus.ca/our-company -
Seqirus | A World Leader in Influenza Vaccines
Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.
https://www.seqirus.ca/ -
Seqirus | Un leader mondial des vaccins antigrippaux
En apprendre plus sur la façon dont nous tirons parti de technologies de pointe et d’une spécialisation éprouvée pour développer des vaccins antigrippaux et répondre aux menaces de pandémie.
https://www.seqirus.ca/fr-fr -
Stephen Marlow
Notre équipe de direction est composée de professionnels expérimentés possédant une spécialisation scientifique approfondie et un engagement commun envers la santé publique. Rencontrez-les maintenant.
https://www.seqirus.ca/fr-fr/notre-compagnie/direction/stephen-marlow -
Russell Basser
Notre équipe de direction est composée de professionnels expérimentés possédant une spécialisation scientifique approfondie et un engagement commun envers la santé publique. Rencontrez-les maintenant.
https://www.seqirus.ca/fr-fr/notre-compagnie/direction/russell-basser -
Seqirus | Key Customer Information
Key Customer Information
https://www.seqirus.ca/key-customer-information -
March 23, 2020
In light of the rapidly developing public health emergency relating to the COVID-19 pandemic, Seqirus Canada would like to inform you about the current actions we are taking to support our customers, to protect the well- being of our workforce, and ensure the continuity of our influenza vaccine operations.
https://www.seqirus.ca/-/media/seqirus-canada/docs-en/seqirus-letter-to-customers-23-march-2020.pdf